Alembic Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Jun' 24	Mar' 24	Dec' 23	Sep' 23	Jun' 23

Sales

1,475.56

1,474.55

1,588.39

1,478.84

1,332.27

Operating profit

291.42

288.19

337.14

207.46

165.73

Interest

12.69

10.13

14.66

15.39

14.29

Gross profit

281.88

285.28

325.78

201.03

163.28

EPS (Rs)

8.96

10.27

11.87

6.81

4.96

Other income

3.15

7.22

3.30

8.95

11.84

Stock adjustment

-111.68

-25.25

10.15

-30.07

-7.20

Raw material

405.93

337.38

317.58

413.87

334.19

Power and fuel

-

-

-

-

-

Employee expenses

356.51

354.92

327.11

326.41

327.47

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

533.37

519.31

596.41

561.18

512.09

Provisions made

-

-

-

-

-

Depreciation

68.68

69.12

69.08

67.18

65.75

Taxation

37.01

14.29

23.46

-

-

Net profit / loss

176.19

201.87

233.24

133.84

97.53

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

39.31

39.31

39.31

39.31

39.31

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

19.75

19.54

21.23

14.03

12.44

GPM (%)

19.06

19.25

20.47

13.51

12.15

NPM (%)

11.92

13.62

14.65

9.00

7.26